Company logo

AGR - Assura Plc

LSE -> Real Estate -> REIT—Healthcare Facilities
Warrington, United Kingdom
Type: Equity

AGR price evolution
AGR
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Current assets
Cash
Short term investments
Net receivables $1603 $1425 $1356 $1674
Inventory $495 $476 $451 $434
Total current assets $3404 $3058 $2751 $3140
Long term investments
Property, plant & equipment $33052 $32264 $31933 $31448
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $43989 $42386 $41606 $41458
Current liabilities
Accounts payable $1924 $1564 $1359 $1578
Deferred revenue
Short long term debt
Total current liabilities $5239 $3927 $4655 $4570
Long term debt $9984 $9919 $8318 $8243
Total noncurrent liabilities
Total debt
Total liabilities $24341 $22947 $22129 $21951
Shareholders' equity
Retained earnings $2015 $1789 $1900 $1985
Other shareholder equity -$25 -$5 -$74 -$131
Total shareholder equity
(in millions $) 31 Jan 2024 31 Jan 2023 30 Mar 2022 30 Mar 2021
Current assets
Cash $243.4 $46.3
Short term investments
Net receivables $1603 $1745 $27.2 $26
Inventory $495 $503 $343 $262
Total current assets $3404 $3210 $348.5 $88.7
Long term investments $3.8 $0.7
Property, plant & equipment $33184 $31296 $2767.6 $2467.2
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $43989 $41123 $3120.5 $2557.1
Current liabilities
Accounts payable $1924 $2046 $2.4 $5.2
Deferred revenue
Short long term debt
Total current liabilities $5239 $4416 $75.1 $66.2
Long term debt $10037 $8303 $1244.4 $948.7
Total noncurrent liabilities
Total debt
Total liabilities $24341 $21743 $1330.9 $1026.4
Shareholders' equity
Retained earnings $2015 $1910 $345.1 $269.2
Other shareholder equity -$25 -$180 $231.2 $231.2
Total shareholder equity $1789.6 $1530.7
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Revenue
Total revenue $1974 $1587 $2466
Cost of revenue
Gross Profit $1492 $1202 $1489
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1403 $1076 $1224
Operating income
Income from continuing operations
EBIT
Income tax expense -$8 $9 -$18
Interest expense -$108 -$95 -$93
Net income
Net income $59 $85 $245
Income (for common shares)
(in millions $) 31 Jan 2024 31 Jan 2023 30 Mar 2022 30 Mar 2021
Revenue
Total revenue $8309 $7923 $136.9 $120.8
Cost of revenue $10.4 $8.8
Gross Profit $5880 $5467 $126.5 $112
Operating activities
Research & development
Selling, general & administrative $12.3 $11.2
Total operating expenses $4950 $4615 $22.8 $20.3
Operating income $114.1 $100.5
Income from continuing operations
EBIT $114.1 $100.5
Income tax expense -$9 $20 -$0.1
Interest expense -$403 -$41 -$28.4 -$25.3
Net income
Net income $786 $881 $155.9 $108.3
Income (for common shares) $155.9 $108.3
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$3099 -$2024 -$1557 -$819
Financing activities
Dividends paid -$681 -$510 -$340 -$170
Sale and purchase of stock
Net borrowings
Total cash flows from financing $2202 $1279 $816 $618
Effect of exchange rate
Change in cash and equivalents $22 $12 -$11 $3
(in millions $) 31 Jan 2024 31 Jan 2023 30 Mar 2022 30 Mar 2021
Net income $155.9 $108.3
Operating activities
Depreciation $0.2 $0.1
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $94.6 $77.4
Investing activities
Capital expenditures
Investments -$3.5 -$0.7
Total cash flows from investing -$3099 -$2548 -$293.9 -$267.5
Financing activities
Dividends paid -$681 -$681 -$75.4 -$61.9
Sale and purchase of stock
Net borrowings $295.9 $108.1
Total cash flows from financing $2202 $108 $396.2 $218.2
Effect of exchange rate
Change in cash and equivalents $22 -$1405 $196.9 $28.1
Fundamentals
Market cap $16.37B
Enterprise value N/A
Shares outstanding 386.77M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 0.65
Quick ratio 0.56